Ontology highlight
ABSTRACT:
SUBMITTER: Isawa M
PROVIDER: S-EPMC6934544 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
Isawa Motoki M Karakawa Akiko A Sakai Nobuhiro N Nishina Saki S Kuritani Miku M Chatani Masahiro M Negishi-Koga Takako T Sato Masashi M Inoue Mitsuko M Shimada Yukie Y Takami Masamichi M
Scientific reports 20191227 1
The anti-bone resorptive drugs denosumab, an anti-human-RANKL antibody, and zoledronic acid (ZOL), a nitrogen-containing bisphosphonate, have recently been applied for treatment of pediatric patients with bone diseases, though details regarding their effects in growing children have yet to be fully elucidated. In the present study, we administered these anti-resorptive drugs to mice from the age of 1 week and continued once-weekly injections for a total of 7 times. Mice that received the anti-RA ...[more]